Dietary intake and weight changes 5 years after laparoscopic sleeve gastrectomy
Wong CH, Bozinovski S, Hertzog PJ, Hickey MJ, Crack PJ
It is important to note that Mounjaro is not licensed for type 1 diabetes or diabetic ketoacidosis
Firstly, it is essential to recognise that allulose should not be viewed as a replacement for prescribed medications or established dietary advice
Current medical evidence does not contraindicate GLP-1 therapy after cholecystectomy, though individual tolerance varies
According to the Summary of Product Characteristics (SmPC), these include: Nausea (very common, affecting more than 1 in 10 people) Diarrhoea (very common) Decreased appetite (very common) Vomiting (common, affecting up to 1 in 10 people) Constipation (common) Abdominal pain (common) Dyspepsia (common) Cholelithiasis (common) Headache (common) These gastrointestinal effects typically occur during the initial weeks of treatment or following dose escalation, and often diminish over time as the body adjusts to the medication